Related Experiment Video
Updated: Mar 27, 2026

03:32
Measurement of Chitinase Activity in Biological Samples
Published on: August 22, 2019
11.0K
Is the Road to Precision Medicine in Chronic Lung Disease Paved with Degraded Chitin?
Agata Wesolowska-Andersen1, Max A Seibold1,2
11 Center for Genes, Environment, and Health National Jewish Health Denver, Colorado and.
American Journal of Respiratory and Critical Care Medicine
|January 16, 2016
Abstract
No abstract available in PubMed .
Related Concept Videos
Cystic Fibrosis: Management
616
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
616
Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K

